Terug
Dagbereik
€ 191,90
€ 198,77
52-Weeksbereik
€ 125,38
€ 256,36
Volume
764.412
50D / 200D Gem.
€ 216,00
/
€ 191,28
Vorige Slotkoers
€ 200,09
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -132,4 | 0,3 |
| P/B | 16,1 | 2,9 |
| ROE % | -14,3 | 3,7 |
| Net Margin % | -9,0 | 3,8 |
| Rev Growth 5Y % | 38,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 249,57
+28.3%
Low: € 172,00
High: € 285,00
Forward WPA
-€ 1,81
Omzet Sch.
2,7 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,28
€ 4,18 – € 4,44
|
5 B | 5 |
| FY2029 |
€ 1,78
€ 1,73 – € 1,84
|
4,4 B | 11 |
| FY2028 |
€ 1,04
-€ 1,15 – € 3,73
|
3,8 B | 13 |
Belangrijkste Punten
Revenue grew 38,57% annually over 5 years — strong growth
Debt/Equity of 0,13 — conservative balance sheet
Generating 109,11M in free cash flow
Capital efficient — spends only 4,60% of revenue on capex
Groei
Revenue Growth (5Y)
38,57%
Revenue (1Y)35,90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-14,32%
ROIC-12,06%
Net Margin-9,03%
Op. Margin-13,44%
Veiligheid
Debt / Equity
0,13
Current Ratio3,39
Interest Coverage-76,16
Waardering
P/E Ratio
-132,44
P/B Ratio16,10
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 35,90% | Revenue Growth (3Y) | 45,95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,57% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,31B | Net Income (TTM) | -208,16M |
| ROE | -14,32% | ROA | -8,30% |
| Gross Margin | 64,85% | Operating Margin | -13,44% |
| Net Margin | -9,03% | Free Cash Flow (TTM) | 109,11M |
| ROIC | -12,06% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 3,39 |
| Interest Coverage | -76,16 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -132,44 | P/B Ratio | 16,10 |
| P/S Ratio | 11,95 | PEG Ratio | 230,22 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 27,57B | Enterprise Value | 26,71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,31B | 1,70B | 1,08B | 820,22M | 625,49M |
| Net Income | -208,16M | -190,43M | -434,80M | -547,80M | -471,72M |
| EPS (Diluted) | -1,52 | -1,53 | -3,78 | -5,57 | -5,21 |
| Gross Profit | 1,50B | 1,02B | 492,74M | 363,97M | 307,07M |
| Operating Income | -309,91M | -222,29M | -446,25M | -541,04M | -468,17M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,51B | 1,66B | 1,44B | 1,39B | 1,24B |
| Total Liabilities | 795,62M | 465,32M | 676,37M | 688,73M | 583,18M |
| Shareholders' Equity | 1,71B | 1,20B | 765,33M | 705,74M | 653,30M |
| Total Debt | 214,38M | 187,12M | 441,99M | 446,22M | 397,23M |
| Cash & Equivalents | 1,08B | 945,59M | 642,10M | 466,09M | 84,39M |
| Current Assets | 1,50B | 1,38B | 1,26B | 1,21B | 1,09B |
| Current Liabilities | 441,23M | 344,05M | 307,27M | 310,50M | 218,96M |